Spellman @AMTZ spells a new Dawn in X-ray Technology in India

Visakhapatnam:  Spellman, the world’s leading manufacturer of X-ray generators, is bringing its state-of-the-art manufacturing facility to the Andhra Pradesh MedTech Zone (AMTZ), marking a significant boost to India’s med-tech capabilities.

As the largest independent supplier of X-ray generators globally, Spellman’s decision to establish its first Indian facility at AMTZ reinforces the zone’s position as a hub for cutting-edge healthcare technology. The company, with a legacy dating back to 1947, has a strong presence across North America, Europe, and Asia and is trusted by Original Equipment Manufacturers (OEMs) for its expertise in medical, industrial, and scientific applications.

The formal commencement of Spellman’s facility setup was marked by a Bhoomi Poojan ceremony at the AMTZ campus, attended by representatives from Spellman’s global leadership, including Mr. Robert J. Frankland, VP Sales from the USA, Ms. Stephanie from China and Arindam Bose from Spellman India.

Emphasizing the significance of this collaboration, Dr. Jitendra Sharma, MD and Founder CEO, AMTZ, said, ‘Having Spellman join Medtech Zone is a monumental step forward for India’s medtech industry. Their Expertise in X-ray technology will drive innovation and strengthen our mission to make healthcare technologies more accessible and affordable.

Spellman’s facility will be the first of its kind in India, manufacturing high-precision X-ray generators and advancing the country’s capabilities in healthcare technology. With over 2,100 employees worldwide and a reputation for innovation, Spellman is expected to catalyze new opportunities for collaboration, knowledge transfer, and economic growth in the region.

The addition of Spellman to AMTZ’s ecosystem highlights the zone’s growing prominence as a destination for global healthcare manufacturers. By fostering partnerships with international leaders like Spellman, AMTZ is paving the way for India to emerge as a key player in the global med-tech industry.

Related Posts

A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

Healthy Heart is a Misnomer until underpinned by Regular Screening Bangaluru/ New Delhi: Of late, heart health has become kind of a veritable conundrum. We were never so unsure of…

Health Ministry Unveils Thalassemia Awareness Posters to Promote Early Screening

The aim is to encourage adolescents and antenatal women to undergo timely thalassemia screening New Delhi: The Ministry of Health and Family Welfare unveiled two awareness posters on thalassemia screening…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Researchers discover a compound that can boost ageing muscle repair

Researchers discover a compound that can boost ageing muscle repair

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months